冠心病慢性心力衰竭患者室性心律失常的临床治疗分析

Clinic Effect on Chronic Heart Failure and Ventricular Arrhythmia

目的探讨冠心病慢性心力衰竭患者室性心律失常的临床治疗效果。方法选取2011年1月至2012年8月我院收治的冠心病慢性心力衰竭合并室性心律失常患者共120例,随机分为实验组和对照组,其中对照组患者采用常规治疗,而实验组患者在此基础上加用胺碘酮治疗。结果实验组患者临床疗效显效、有效、无效分别为31例(51.67%)、22例(36.67%)、7例(11.67%),总有效率达88.33%;而对照组患者临床疗效显效、有效、无效分别为13例(21.67%)、25例(41.67%)、22例(36.67%),总有效率为63.33%。两组患者总有效率差异存在统计学意义(P<0.05),说明实验组患者的总有效率明显高于对照组患者。结论胺碘酮配合常规治疗冠心病慢性心力衰竭合并室性心律失常具有较佳的临床效果。

Objective Learn the clinic effect on coronary chronic heart failure and ventricular arrhythmia. Methods 120 patients of coronary chronic heart failure and ventricular arrhythmia from January 2011 to August 2012 divided into two groups. The control group used common therapy while the experiment group used amiodarone in this basis. Results The excellence rate, effective rate and inefficiency rate of the experiment group were respectively 51.67% （31 cases）, 36.67% （22 cases） and II.67% （7 cases）. The excellence rate, effective rate and inefficiency rate of the control group were respectively 21.67% （13 cases）, 41.67% （25 cases） and 36.67% （22 cases）. The total effective rate of two groups had signiticance（P〈0.05）. The total effective rate of experiment group （88.33%） was obviously higher than control group （63.33%）. Concluslon Amiodarone combine with common therapy has a better clinic effect on coronary chronic heart failure and ventricular arrhythmia.